Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies

Summary of sales allowances and related accruals

	Customer credits,		Rebates and co-pay
		discounts and allowances		assistance		Product returns
	(contra accounts receivable)		(accrued expenses)		(accrued expenses)		Total
Balance as of December 31, 2021	$	371	$	528	$	141	$	1,040
Allowances for current period sales		5,891		4,035		399		10,325
Payments and credits		(3,268)		(2,574)		(197)		(6,039)
Balance as of December 31, 2022		2,994		1,989		343		5,326
Allowances for current period sales		18,385		8,192		2,964		29,541
Payments and credits		(16,665)		(5,564)		(1,432)		(23,661)
Balance as of December 31, 2023	$	4,714	$	4,617	$	1,875	$	11,206

Schedule of outstanding potentially dilutive securities excluded from calculation of diluted net loss per share

The following table sets forth the outstanding potentially dilutive securities that have been excluded from the calculation of diluted net loss per share for the years ended December 31, 2023, 2022 and 2021, respectively, because to do so would be anti-dilutive (in common equivalent shares):

	Year Ended December 31,
	2023	2022	2021
Common stock warrants	5,589,637	1,130,025	7,592
Unvested restricted stock units	173,517	129	167
Common stock options	43,043	7,956	5,183
Total	5,806,197	1,138,111	12,941